Cargando…
Incidence of clinically relevant psychiatric symptoms during glioblastoma treatment: an exploratory study
PURPOSE: In addition to neurological symptoms glioblastoma (GBM) patients can experience psychiatric complaints, which are often hard to recognize and difficult to treat. Research on psychiatric symptoms during glioblastoma treatment is limited, but can have significant impact on quality of life, tr...
Autores principales: | Regli, L. K. P., Huijs, S. M. H., Pasmans, R. C. O. S., Leue, C., Dijkstra, J. B., Eekers, D. B. P., Hovinga, K. E., Anten, M. H. M. E., Hoeben, A., Broen, M. P. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232638/ https://www.ncbi.nlm.nih.gov/pubmed/37162667 http://dx.doi.org/10.1007/s11060-023-04326-2 |
Ejemplares similares
-
Temporal muscle thickness as an independent prognostic imaging marker in newly diagnosed glioblastoma patients: A validation study
por: Broen, Martinus P G, et al.
Publicado: (2022) -
Correlation of reduced temporal muscle thickness and systemic muscle loss in newly diagnosed glioblastoma patients
por: ten Cate, Cecil, et al.
Publicado: (2022) -
Clinical implementation of standardized neurocognitive assessment before and after radiation to the brain
por: Zegers, C.M.L., et al.
Publicado: (2023) -
Noninvasive Glioblastoma Testing: Multimodal Approach to Monitoring and Predicting Treatment Response
por: Verduin, Maikel, et al.
Publicado: (2018) -
Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial
por: Compter, Inge, et al.
Publicado: (2020)